
LXRX
Healthcare · Biotechnology · $797.0M market cap
$1.79-0.03 (-1.6%)Nov 13, 4:27 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -50.1% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | Before the open | -0.06 | -0.03 | +50.0% |
| Aug 6, 2026 | Before the open | -0.06 | -0.06 | 0.0% |
| May 7, 2026 | Before the open | -0.04 | -0.00 | +93.5% |
| Mar 5, 2026 | Time not confirmed | -0.07 | -0.04 | +40.3% |
| Nov 6, 2025 | Before the open | -0.07 | -0.04 | +42.9% |
| Aug 6, 2025 | Before the open | -0.08 | 0.01 | +112.5% |
| May 13, 2025 | After the close | -0.10 | -0.07 | +30.0% |
| Mar 10, 2025 | Before the open | -0.12 | -0.09 | +27.9% |
| Nov 12, 2024 | After the close | -0.17 | -0.18 | -5.9% |
| Aug 1, 2024 | After the close | -0.19 | -0.17 | +10.5% |
| May 2, 2024 | After the close | -0.20 | -0.20 | 0.0% |
| Mar 11, 2024 | Before the open | -0.23 | -0.20 | +13.0% |
| Nov 8, 2023 | Before the open | -0.22 | -0.21 |
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA…
| +4.5% |
| Aug 3, 2023 | After the close | -0.16 | -0.22 | -37.5% |
| May 2, 2023 | After the close | -0.16 | -0.17 | -6.3% |
| Mar 2, 2023 | After the close | -0.13 | -0.16 | -23.1% |
| Nov 9, 2022 | After the close | -0.14 | -0.13 | +7.1% |
| Aug 2, 2022 | After the close | -0.16 | -0.16 | 0.0% |
| May 5, 2022 | Before the open | -0.17 | -0.16 | +5.9% |
| Feb 28, 2022 | Before the open | -0.18 | -0.17 | +5.6% |
| Nov 3, 2021 | After the close | -0.18 | -0.16 | +11.1% |
| Jul 30, 2021 | Before the open | -0.20 | -0.13 | +35.0% |
| May 6, 2021 | After the close | -0.21 | -0.15 | +28.6% |
| Mar 10, 2021 | After the close | -0.28 | -0.04 | +85.7% |
| Oct 29, 2020 | Before the open | -0.12 | -0.42 | -250.0% |
| Jul 29, 2020 | After the close | -0.72 | -0.63 | +12.5% |
| Apr 27, 2020 | Before the open | -0.81 | -0.63 | +22.2% |
| Mar 12, 2020 | Before the open | -0.92 | -0.48 | +47.8% |
| Nov 7, 2019 | Before the open | 1.30 | 2.18 | +67.7% |
| Jul 31, 2019 | Before the open | -0.09 | -0.22 | -144.4% |
| May 1, 2019 | Before the open | -0.24 | -0.21 | +12.5% |
| Mar 13, 2019 | Before the open | -0.29 | -0.16 | +44.8% |
| Nov 1, 2018 | Before the open | -0.35 | -0.26 | +25.7% |
| Jul 30, 2018 | Before the open | -0.37 | -0.33 | +10.8% |
| May 3, 2018 | Before the open | -0.44 | -0.40 | +9.1% |
| Feb 22, 2018 | Before the open | -0.41 | -0.31 | +24.4% |